<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of this study was to review, summarize and analyze recent findings relevant to the contribution of neuroimaging to the diagnosis of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) </plain></SENT>
<SENT sid="1" pm="."><plain>Computerized tomography (CT) or magnetic resonance imaging (MRI) provide accurate demonstration of the location and rate of progression of atrophic changes affecting the brain in AD and the different types of vascular lesions observed in mixed <z:hpo ids='HP_0000726'>dementias</z:hpo> and in pure VaD </plain></SENT>
<SENT sid="2" pm="."><plain>Quantification of cortical thickness allows early diagnosis and rate of progression from mild <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> (MCI) to <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>White matter involvement can also be quantified with diffusion tensor imaging (DTI) and functional methods including fMRI, functional connectivity, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> spectroscopy (MRS) </plain></SENT>
<SENT sid="4" pm="."><plain>Isotope-based techniques such as <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography (PET) allow measurement of regional cerebral <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism using (18)F-2-fluoro-deoxy-<z:chebi fb="0" ids="4167">D-glucose</z:chebi> (FDG) </plain></SENT>
<SENT sid="5" pm="."><plain>Cerebral blood flow can be measured using PET with H(2)(15)O or withÂ single <z:chebi fb="23" ids="30212">photon</z:chebi> emission computerized tomography (SPECT) with <z:chebi fb="1" ids="33353">technetium</z:chebi> ((99m)Tc-HMPAO) or, more recently, arterial <z:chebi fb="0" ids="35210">spin label</z:chebi> (ASL) imaging </plain></SENT>
<SENT sid="6" pm="."><plain>There are isotope markers for amyloid-beta ((11)O-<z:chebi fb="0" ids="53725">PIB</z:chebi>, (18)F-florbetapir), tau ((18)FDDNP) and activated microglia ((11)C-PK11195) </plain></SENT>
<SENT sid="7" pm="."><plain>Neuroimaging markers are particularly useful at the early symptomatic and preclinical asymptomatic phases of AD, as well as serving as endpoints in clinical trials </plain></SENT>
</text></document>